This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Immunitas Therapeutics, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Elizabeth Scanlon: Innovator in Antibody Therapeutics
Introduction
Elizabeth Scanlon is a prominent inventor based in Allston, MA (US). She has made significant contributions to the field of antibody therapeutics, particularly in the development of anti-CD161 antibodies. With a total of 2 patents to her name, her work is paving the way for new treatment options for various disorders.
Latest Patents
Elizabeth's latest patents focus on anti-CD161 antibodies and their uses. The inventions relate to pharmaceutical compositions that comprise these antibodies and methods for utilizing them in treating disorders associated with or mediated by CD161, including certain cancers. Additionally, her patents cover expression vectors and host cells designed for the production of these antibodies.
Career Highlights
Elizabeth is currently affiliated with Immunitas Therapeutics, Inc., where she continues to advance her research in antibody development. Her innovative work is crucial in the ongoing fight against cancer and other related disorders.
Collaborations
Some of her notable coworkers include Alison Tisdale and Uli Bialucha, who contribute to the collaborative environment at Immunitas Therapeutics, Inc.
Conclusion
Elizabeth Scanlon's contributions to the field of antibody therapeutics exemplify her dedication to innovation and research. Her work is instrumental in developing new treatments that could significantly impact patient care.